Weight Loss for PCOS: Diet, Exercise and Medication

Weight loss for PCOS is a common concern, as polycystic ovary syndrome creates genuine hormonal and metabolic barriers that make managing body weight more difficult than it is for people without the condition. Insulin resistance, elevated androgens and disrupted appetite regulation all contribute to increased fat storage and persistent hunger. The good news is that even modest weight loss can produce meaningful improvements in hormonal balance, menstrual regularity and metabolic health. This article explains why PCOS makes weight management harder, which approaches are most effective, what medications are available in the UK, and what the NHS recommends.

Why is losing weight harder with PCOS?

Insulin resistance and elevated androgens in PCOS promote abdominal fat storage, suppress fat breakdown and drive persistent hunger, creating physiological barriers to weight loss that go beyond willpower.

Losing weight with polycystic ovary syndrome (PCOS) is genuinely harder than it is for people without the condition, primarily because of the hormonal and metabolic disruptions that define it. PCOS is characterised by elevated androgen levels, irregular ovulation and, in many cases, insulin resistance, a state in which the body's cells respond poorly to insulin and the pancreas compensates by producing more of it.^[1][2] Chronically high insulin levels are associated with increased fat storage, particularly around the abdomen, and may suppress fat breakdown, making a calorie deficit harder to achieve and sustain.^[17][18] It is worth noting that not everyone with PCOS has insulin resistance or is overweight; the condition presents across a range of phenotypes, including lean PCOS.

Insulin resistance is also associated with greater post-meal blood glucose fluctuations, which may contribute to persistent hunger and carbohydrate cravings. This is not a matter of willpower: the hormonal environment in PCOS creates physiological pressure to eat more and store more. Research, including systematic reviews published in journals such as the Journal of Clinical Endocrinology and Metabolism, has consistently found a higher prevalence of insulin resistance in women with PCOS compared with matched controls, including those at a healthy body weight.^[16][17] The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS (Monash University, ESHRE and ASRM) summarises this evidence and is a key reference for clinicians and patients alike.^[1][2]

Androgen excess adds a further layer of difficulty. Higher testosterone levels are associated with a tendency to accumulate visceral (deep abdominal) fat, which is metabolically active and linked to worsening insulin resistance, creating a self-reinforcing cycle. Disrupted sleep, which is more common in PCOS, and the psychological burden of a chronic condition may also influence cortisol levels and appetite-regulating hormones such as leptin and ghrelin, though the precise mechanisms remain an area of ongoing research.

Which approaches to weight loss actually work for PCOS?

A low glycaemic index or Mediterranean-style diet combined with at least 150 minutes of moderate activity per week is the most evidence-supported approach, with 5 to 10 per cent weight loss improving ovulation and androgen levels.

A combination of dietary modification and regular physical activity remains the most evidence-supported approach to weight loss for people with PCOS, with even modest reductions in body weight producing meaningful hormonal improvements. The 2023 International Evidence-Based Guideline for PCOS notes that losing 5 to 10 per cent of body weight can restore more regular ovulation, reduce androgen levels and improve insulin sensitivity in women with PCOS, even when a healthy BMI is not reached.^[1][2]

Dietary approaches that reduce glycaemic load tend to be particularly effective. A low glycaemic index (GI) diet, which prioritises foods that release glucose slowly, such as wholegrains, legumes, non-starchy vegetables and lean proteins, may help to moderate insulin spikes and reduce cravings. Some evidence, including Cochrane reviews and the 2023 International PCOS Guideline, also supports a Mediterranean-style eating pattern, which is rich in unsaturated fats, fibre and plant-based foods. Very low calorie diets can produce rapid short-term results but are difficult to sustain and should only be undertaken with clinical supervision.

For physical activity, both aerobic exercise (such as brisk walking, cycling or swimming) and resistance training have demonstrated benefits in PCOS. Resistance training is particularly useful because it is associated with improved insulin sensitivity and increased lean muscle mass, which raises resting metabolic rate.^[1][2] The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, and this target is a reasonable starting point for most people with PCOS.^[15]

Behavioural support, including structured programmes with regular check-ins, goal-setting and cognitive strategies for managing emotional eating, is associated with significantly improved long-term adherence. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be one route to accessing structured guidance alongside lifestyle changes.

Can medication help with weight loss if you have PCOS?

Prescription medicines including metformin, semaglutide (Wegovy), tirzepatide (Mounjaro), orforglipron (Foundayo) and orlistat can support weight management in PCOS when lifestyle changes alone are insufficient.

Medication can play a supportive role in weight management for people with PCOS, particularly when lifestyle changes alone have not produced sufficient results. The most commonly used medicine in this context is metformin, a biguanide that reduces hepatic glucose production and improves insulin sensitivity. Although metformin is not licensed specifically for weight loss, NICE Clinical Knowledge Summary (CKS) for Polycystic Ovary Syndrome acknowledges its use in PCOS for managing metabolic features, and it is sometimes prescribed off-label to support weight management in women with insulin resistance.^[3][4] Common side effects include nausea, diarrhoea and abdominal discomfort, which are usually dose-dependent and often improve over time.

Several medicines are licensed in the UK specifically for chronic weight management. Semaglutide (Wegovy) is MHRA-authorised for chronic weight management in adults with a BMI of 30 kg/m2 or above, or 27 kg/m2 or above with at least one weight-related comorbidity.^[5] Wegovy is available in doses up to 2.4 mg weekly, with a higher 7.2 mg strength also authorised by the MHRA. Tirzepatide (Mounjaro) is a dual GIP and GLP-1 receptor agonist authorised in the UK both for type 2 diabetes and for chronic weight management.^[8][9] These medicines work by acting on gut hormone receptors that regulate appetite and slow gastric emptying, reducing hunger and calorie intake. Orforglipron (Foundayo) is a further MHRA-authorised oral option for chronic weight management; a prescriber can advise whether it may be suitable.^[11][12] Orlistat, which reduces dietary fat absorption, is another licensed option and may be considered where other therapies are not suitable; it has important interactions with medicines such as ciclosporin and warfarin, and is not suitable for people with chronic malabsorption or cholestasis. Common side effects of GLP-1 and dual GIP/GLP-1 medicines include nausea, vomiting and constipation, particularly during dose escalation.

All of these medicines are prescription-only. Any decision about medication should involve a prescriber who can assess individual circumstances, contraindications and suitability. Women of childbearing potential should discuss contraception with their prescriber before starting weight-management medicines, as GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists and orlistat are not recommended during pregnancy or breastfeeding; the relevant SmPCs should be consulted for specific washout periods and contraception advice. If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

What does the NHS recommend for managing PCOS and weight?

NICE CKS recommends lifestyle intervention as first-line treatment, with GP referral to specialist services or structured weight-management programmes where needed, and regular metabolic screening for associated conditions.

The NHS recommends a structured, multidisciplinary approach to PCOS management, with weight management as a central component for those who are overweight or obese. NICE Clinical Knowledge Summary (CKS) for Polycystic Ovary Syndrome and the NHS patient information on PCOS both emphasise that lifestyle intervention, including dietary change and increased physical activity, should be the first-line strategy for managing weight-related symptoms of PCOS. Clinical guidance notes that even modest weight loss can improve hormonal profiles, menstrual regularity and fertility outcomes.

NHS services for PCOS are typically coordinated through a GP, who may refer to a gynaecologist, endocrinologist or specialist PCOS clinic depending on the presenting symptoms. For women whose primary concern is weight, referral to a structured weight management programme, such as those commissioned locally by Integrated Care Boards (ICBs), may be appropriate. Access to specialist weight-management medicines on the NHS depends on local ICB commissioning decisions and clinical eligibility criteria, and availability varies across England, Scotland, Wales and Northern Ireland.

The NHS also recommends that women with PCOS are screened regularly for associated metabolic risks, including type 2 diabetes, hypertension and dyslipidaemia, as these conditions are more prevalent in this population. A fasting glucose or HbA1c test is typically recommended at diagnosis and periodically thereafter, in line with NICE CKS guidance.^[4] Women should contact their GP if they experience significant weight gain, worsening symptoms, or if they are planning a pregnancy, as management priorities may shift. For urgent concerns, NHS 111 can provide advice outside of GP hours.

How lifestyle changes affect PCOS symptoms beyond the scales

Modest weight loss reduces visceral fat, lowering insulin and androgen levels, which can restore menstrual regularity, reduce hirsutism and improve mental health, independently of reaching a target BMI.

Weight loss in PCOS produces benefits that extend well beyond the number on the scales, with improvements in hormonal balance, menstrual regularity and psychological wellbeing all documented in clinical literature. A reduction in body fat, particularly visceral fat, is associated with lower circulating insulin and androgen levels, which may lead to more regular menstrual cycles, reduced hirsutism (excess hair growth) and improvement in acne. These changes can occur with relatively modest weight loss, reinforcing the value of sustainable lifestyle change over rapid but unsustainable dieting.

Regular physical activity has independent benefits in PCOS that are not solely mediated by weight loss. Exercise is associated with improved insulin sensitivity at the cellular level and reduced systemic inflammation, and may support mental health. Given that anxiety and depression are significantly more prevalent in women with PCOS than in the general population, as documented in systematic reviews, the psychological benefits of structured activity should not be underestimated.^[20][21] NHS Talking Therapies and other mental health support services are available for those who need additional help.

Dietary quality may also influence PCOS symptoms independently of calorie intake. Reducing ultra-processed foods and added sugars, and increasing dietary fibre and omega-3 fatty acids, has been associated with reductions in inflammatory markers and improvements in lipid profiles in women with PCOS, though most evidence is from observational studies and the direction of causality is not always clear. Adequate sleep, stress management and limiting alcohol intake are additional lifestyle factors that may influence cortisol, insulin and androgen levels.

It is worth noting that not all symptoms of PCOS will resolve with weight loss alone, and some women will continue to require medical management for features such as anovulation or significant hyperandrogenism. Regular review with a GP or specialist ensures that the management plan evolves alongside the individual's needs and goals.

Frequently Asked Questions